Iteos Therapeutics, Inc.
ITOS
Revenue
35.00M
▲35.00M∞%
3 Months ChangeAssets
751.84M
▲122.07M▲19.38%
3 Months ChangeLiabilities
87.97M
▼-596.00k▼-0.6729%
3 Months ChangeFree Cash Flow
-33.35M
▼-6.67M▼-25.01%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0000950170-24-106606
2024-08-08
Form 10-Q
ID: 0000950170-24-093302
2024-06-13
Form 8-K
ID: 0000950170-24-072973
2024-05-13
Form 8-K
ID: 0001193125-24-136682
2024-05-10
Form 10-Q
ID: 0000950170-24-057472
2024-01-10
Form 8-K
ID: 0000950170-24-003664
2023-12-07
Form 8-K
ID: 0000950170-23-068807
2023-11-07
Form 10-Q
ID: 0000950170-23-059757
2023-08-08
Form 10-Q
ID: 0000950170-23-039341
2023-06-26
Form 8-K
ID: 0000950170-23-029730